Market Place
Sourcing Support
Axplora initiates global investments exceeding €100m in 2025
08 Oct 2025 //
PRESS RELEASE
Axplora Announces €6.5 Million Investment at Vizag Site
05 Aug 2025 //
PRESS RELEASE
Axplora Doubles Farmabios Footprint with €35M Expansion
04 Jul 2025 //
PRESS RELEASE
Axplora’s Chasse-sur-Rhône CDMO Site in France Passes Inspection
04 Jun 2025 //
PRESS RELEASE
Axplora Launches Payload Manufacturing Workshop in France
04 Mar 2025 //
PRESS RELEASE
Axplora Boosts GLP-1 Manufacturing with €50M Investment in France
13 Feb 2025 //
PRESS RELEASE
The Road Ahead for Small Molecule APIs in 2025
09 Feb 2025 //
PRESS RELEASE
Martin Meeson appointed as CEO of Axplora
10 Apr 2024 //
PRESS RELEASE
Axplora plans €8m investment at French facility
30 Jan 2024 //
PRESS RELEASE
Axplora announces the appointment of its Scientific Advisory Board
13 Nov 2023 //
PRESS RELEASE
Axplora announces the appointment of its Scientific Advisory Board
13 Nov 2023 //
PRESS RELEASE
Axplora`s Ursodeoxycholic Receives 5-Year Renewed Registration
07 Nov 2023 //
PRESS RELEASE
Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit
18 Oct 2023 //
PRESS RELEASE
Code of Business Conduct: a key milestone for Axplora’s compliance program
04 Oct 2023 //
PRESS RELEASE
A leading manufacturer of active, life-saving pharmaceutical ingredients: Axplora
02 Oct 2023 //
PRESS RELEASE
Axplora Unveils New cGMP Pilot Facility for Flow Chemistry
25 Jul 2023 //
PRESS RELEASE
A new cGMP pilot facility for flow chemistry
25 Jul 2023 //
PRESS RELEASE
Axplora Aims to Make Pharmaceutical Supply Chains More Stable
22 Mar 2023 //
CHEMANAGER
Exclusive negotiations with InnovaFonds on the acquisition of Novasep Process Solutions
02 Feb 2023 //
PRESS RELEASE
Axplora Receives Pharmaceutical Establishment License for Le Mans Site
15 Dec 2022 //
PRESS RELEASE
Farmabios, Novasep and PharmaZell are now Axplora
20 Oct 2022 //
PRESS RELEASE
Novasep-PharmaZell invests €7.3M to increase API production capac
21 Jul 2022 //
ADCREVIEW
Safe HPAPI manufacturing: Thinking outside the glovebox!
20 Jul 2022 //
PRESS RELEASE
PharmaZell & Novasep announce the creation of a leading CDMO API
07 Apr 2022 //
PRESS RELEASE
Novasep invests €5.1 million in Le Mans to further expand its pro
15 Mar 2022 //
OUTSOURCED PHARMA
Novasep & Paratek enhance collaboration to manufacture omadacycli
15 Feb 2022 //
MANUFACTURING CHEMIST
Sartorius completes acquisition of Novasep’s chromatography equipment division
02 Feb 2022 //
PRESS RELEASE
Novasep signs a letter of intent Pfizer to bepart of the global supply PAXLOVID
17 Jan 2022 //
REUTERS
Novasep Invests €6M to Expand API Capacity at Chasse-sur-Rhône
09 Dec 2021 //
CONTRACTPHARMA
Fitch Affirms European Medco Development 3 S.a.r.l.`s IDR at `B` on Novasep Acquisition
25 Oct 2021 //
FITCHRATINGS
Breckenridge Announces Approval of its ANDA for Teriflunomide Tablets (generic for Aubagio®)
29 Sep 2021 //
PRNEWSWIRE
PharmaZell and Novasep discuss merger to create leader in small m
17 Sep 2021 //
PR NEWSWIRE
Novasep Upgrades API Manufacturing Facility
25 Jun 2021 //
CONTRACTPHARMA
Novasep invests $7.3M in API manufacturing facility in France
24 Jun 2021 //
BIOSPECTRUMASIA
Novasep Expands HPAPI Manufacturing Capacity
13 May 2021 //
CONTRACTPHARMA
Novasep upgrades plant capacity for next-gen cancer meds
11 May 2021 //
FIERCEPHARMA
JPM: Thermo Fisher picks up Novasep’s viral vector arm for $878M
15 Jan 2021 //
FIERCE BIOTECH
Sartorius Stedim Biotech to acquire Novasep`s chromatography process division
06 Jan 2021 //
BIOSPACE
Novasep to Invest $7.6 million to Expand API Manufacturing Workshop Capacity
11 Nov 2020 //
PHARMTECH
Novasep invests €6.5 million in accelerating API manufacturing in France
10 Nov 2020 //
BIOSPECTRUMASIA
Sensorion and Novasep Announce Signature of a Gene Therapy
27 Oct 2020 //
BUSINESSWIRE
Private Equity owner Bridgepoint visits PharmaZell Group’s compan
14 Oct 2020 //
PRESS RELEASE
Novasep implements new Biopharma Solutions Business Unit, led by Cédric Volanti
03 Mar 2020 //
PR NEWSWIRE
PharmaZell Group acquired by Bridgepoint
14 Feb 2020 //
PRESS RELEASE
Bankers line up billions in debt as M&A pipeline builds
13 Feb 2020 //
REUTERS
Novasep launches oXYgene™, a fully integrated offer for boosting viral vector
02 Dec 2019 //
PR NEWSWIRE
Deals of the day-Mergers and acquisitions
07 Nov 2019 //
REUTERS
DPE to ship German pharmaceutical biz
07 Nov 2019 //
PITCHBOOK
German pharma ingredients maker PharmaZell put up for sale: sources
06 Nov 2019 //
REUTERS
Senefill, Novasep`s commercial facility for filling & finishing operations
01 Oct 2019 //
PR NEWSWIRE
Farmabios expands its portfolio with Cannabidiol API
11 Sep 2019 //
PRESS RELEASE
Bluebird Bio delays Zynteglo launch
20 Jun 2019 //
FIERCE PHARMA
NOVASEP & THERAVECTYS enter into a new license agreement on DNA Flap Technology
16 Apr 2019 //
PRESS RELEASE
Sartorius, Novasep Enter Bioprocessing Alliance
05 Mar 2019 //
CONTRACT PHARMA
Novasep announces the success of its consent solicitation extending the maturity
20 Feb 2019 //
PRESS RELEASE
Enzene Biosciences chooses Novasep BioSC® Pilot chromatography for its automated
04 Feb 2019 //
PRESS RELEASE
Novasep announces the launch of a consent solicitation for maturity extension
31 Jan 2019 //
PRESS RELEASE
Novasep industrializes potato protein purification unit for Solanic B.V.
22 Oct 2018 //
PRESS RELEASE
